AnGes raises $11.2 million

Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) raised Y1.1 billion ($11.2 million) after Merrill Lynch Japan Securities exercised 4,000 stock acquisition rights at Y287,100. Each right entitles Merrill to purchase a share at 90% of the previous day's closing price, with a minimum exercise price of Y253,600. Merrill now has 16,000 acquisition rights outstanding. The rights are exercisable through May 19, 2014. AnGes was off Y41,000 (13%) to Y270,000 on Thursday. ...